Cited by

• JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

  Khanna N, Wolbers M, Mueller NJ, Garzoni C, Du Pasquier RA, Fux CA, Vernazza P, Bernasconi E, Viscidi R, Battegay M, Hirsch HH; Swiss HIV Cohort Study. Khanna N, et al. J Virol. 2009 May;83(9):4404-11. doi: 10.1128/JVI.02657-08. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211737 Free PMC article.
• Detection Analysis and Study of Genomic Region Variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the Urine and Plasma of HIV-1-Infected Patients.

  Passerini S, Prezioso C, Prota A, Babini G, Coppola L, Lodi A, Epifani AC, Sarmati L, Andreoni M, Moens U, Pietropaolo V, Ciotti M. Passerini S, et al. Viruses. 2022 Nov 17;14(11):2544. doi: 10.3390/v14112544. Viruses. 2022. PMID: 36423152 Free PMC article.
• Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

  Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO. Ferenczy MW, et al. Clin Microbiol Rev. 2012 Jul;25(3):471-506. doi: 10.1128/CMR.05031-11. Clin Microbiol Rev. 2012. PMID: 22763635 Free PMC article. Review.
• Case 15: when a stroke is not a stroke.

  Burnette WB. Burnette WB. MedGenMed. 2007 Jan 30;9(1):21. MedGenMed. 2007. PMID: 17435628 Free PMC article. No abstract available.
• Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.

  Sottini A, Capra R, Zanotti C, Chiarini M, Serana F, Ricotta D, Caimi L, Imberti L. Sottini A, et al. PLoS One. 2012;7(4):e34493. doi: 10.1371/journal.pone.0034493. Epub 2012 Apr 4. PLoS One. 2012. PMID: 22496817 Free PMC article.